WallStreetZenWallStreetZen

NYSE: CRL
Charles River Laboratories International Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Charles River Laboratories International earnings were $413.1M for the trailing 12 months ending Sep 28, 2024, with -13.4% growth year over year. The latest CRL earnings report on Sep 28, 2024 announced Q3 2024 earnings of $68.7M, down 23.7% from last quarter. For the last reported fiscal year 2023 ending Dec 30, 2023, CRL reported annual earnings of $474.6M, with -2.4% growth. The next CRL earnings date is Feb 12, 2025.

CRL past earnings growth

How has CRL's earnings growth performed historically?

Company
-13.44%
Industry
-6.64%
Market
48.58%
CRL's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CRL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CRL's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CRL earnings history

Current Revenue
$4.1B
Current Earnings
$413.1M
Current Profit Margin
10.2%
CRL's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CRL Return on Equity

Current Company
11.2%
Current Industry
-13.8%
Current Market
35%
CRL's Return on Equity (11.2%)... subscribe to Premium to read more.
High Return on Equity Performance

CRL Return on Assets

Current Company
5.1%
Current Industry
5.9%
CRL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRL announces earnings.

CRL Return on Capital Employed

Current Company
9.24%
Current Industry
10.5%
CRL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRL vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRL$986.15M$413.08M+10.99%$8.05
QGEN$368.60M$92.93M-19.32%$0.37
EXAS$58.24M-$214.04MN/A-$1.17
MEDP$464.88M$365.67M+35.29%$11.83
RVTY$729.58M$254.30M-0.29%$2.08
View Top Diagnostic & Research Stocks

CRL earnings dates

Next earnings date
Feb 12, 2025

Charles River Laboratories International Earnings Reports & History FAQ

What were Charles River Laboratories International's earnings last quarter?

On CRL's earnings call on Invalid Date, Charles River Laboratories International (NYSE: CRL) reported Q3 2024 earnings per share (EPS) of $1.34, up 21.18% year over year. Total CRL earnings for the quarter were $68.68 million. In the same quarter last year, Charles River Laboratories International's earnings per share (EPS) was $1.70.

If you're new to stock investing, here's how to buy Charles River Laboratories International stock.

When does Charles River Laboratories International report earnings?

The next CRL earnings call is Invalid Date. Add CRL to your watchlist to be reminded of Charles River Laboratories International's next earnings date.

What was CRL's earnings growth in the past year?

As of Charles River Laboratories International's earnings date in Invalid Date, Charles River Laboratories International's earnings has grown -13.44% year over year. This is 6.8 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -6.64%. CRL earnings in the past year totalled $413.08 million.

Is Charles River Laboratories International profitable or losing money?

As of the last Charles River Laboratories International earnings report, Charles River Laboratories International is currently profitable. Charles River Laboratories International's net profit (also called net income) for the twelve months ending Sep 28, 2024 was $423.78 million, a 10.77% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.